Flossbach von Storch AG Zurich’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$878K Sell
9,575
-43,400
-82% -$4.16M 7.33% 7
2020
Q1
$4.78M Buy
52,975
+24,475
+86% +$2.6M 7.88% 6
2019
Q4
$3.23M Hold
28,500
2.73% 16
2019
Q3
$3.1M Hold
28,500
3.44% 12
2019
Q2
$2.78M Buy
28,500
+10,000
+54% +$913K 3.28% 13
2019
Q1
$1.69M Hold
18,500
2.05% 16
2018
Q4
$1.68M Buy
+18,500
New +$1.73M 1.56% 23

Other funds holding MDT

Flossbach von Storch AG Zurich's MDT Position: Q2 2020 in Review

Flossbach von Storch AG Zurich reduced its Medtronic (MDT) stake by 82% in Q2 2020, selling an estimated $4.16M and leaving 9,575 shares worth $878K. The position accounts for 7.33% of the portfolio, ranked #7.

Flossbach von Storch AG Zurich first reported a position in MDT in Q4 2018 and has held it in 7 quarters since. The position peaked at $4.78M in Q1 2020. 1,760 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

  • Flossbach von Storch AG Zurich held 9,575 shares of Medtronic worth $878K as of Q2 2020.
  • Flossbach von Storch AG Zurich sold 43,400 Medtronic shares in Q2 2020, an estimated $4.16M.
  • Medtronic made up 7.33% of Flossbach von Storch AG Zurich's portfolio in Q2 2020, its #7 holding.
  • Flossbach von Storch AG Zurich first reported a position in Medtronic in Q4 2018 and has held it in 7 quarters since.
  • Flossbach von Storch AG Zurich's Medtronic position peaked at $4.78M in Q1 2020.
  • 1,760 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on Flossbach von Storch AG Zurich's 13F filing for Q2 2020, filed 12 Aug 2020.